Expanding the clinicopathological spectrum of succinate dehydrogenase-deficient renal cell carcinoma with a focus on variant morphologies: a study of 62 new tumors in 59 patients
Talia L. Fuchs, Fiona Maclean, John Turchini, Ana Cristina Vargas, Selina Bhattarai, Abbas Agaimy, Arndt Hartmann, Chia‐Sui Kao, Carla L. Ellis, Michael Bonert, Xavier Leroy, Lakshmi P. Kunju, Lauren E. Schwartz, Admire Matsika, Sean R. Williamson, Priya Rao, Mukul Divatia, Rosa Guarch, Ferrán Algaba, Marcelo Luiz Balancin, Ming Zhou, Hemamali Samaratunga, Isabela Werneck da Cunha, Fadi Brimo, Andrew Ryan, David Clouston, Manju Aron, Marie O’Donnell, Emily Chan, Michelle S. Hirsch, Holger Moch, Chun-Yin Pang, Wah Cheuk, Weihua Yin, Joanna Perry‐Keene, Aslı Yilmaz, Angela Chou, Adele Clarkson, Gerhard van der Westhuizen, Ella Morrison, Jonathan Zwi, Ondřej Hes, Kiril Trpkov, Anthony J. Gill
Topics & Concepts
PathologyRenal cell carcinomaSDHBEosinophilicImmunohistochemistrySDHAGrading (engineering)MedicineClear cellBiologySuccinate dehydrogenaseGermline mutationMutationEcologyBiochemistryEnzymeGeneRenal cell carcinoma treatmentCancer, Hypoxia, and MetabolismRenal and related cancers